Skip to content

Clinical trials

Hematologic Diseases trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Country / region: Norway Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20161
20181
20191
20212
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cogent Biosciences, Inc.2
Pfizer2
Swedish Orphan Biovitrum2
Cellphire Therapeutics, Inc.1
Hutchmed1
Loxo Oncology, Inc.1
Novartis Pharmaceuticals1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases11
Hemorrhagic Disorders4
Immune System Diseases4
Blood Coagulation Disorders3
Hemorrhage3
Thrombocytopenia3
Autoimmune Diseases2
Blood Platelet Disorders2
Coagulation Protein Disorders2
Genetic Diseases, Inborn2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.